Princeton Biotech Consulting was founded by Dr. Sauder who is skilled in drug development, from concept and strategy development through FDA approval, including: medical writing and clinical development strategies from bench to bedside. His experience in executing development programs to gain FDA registration of drugs and biologics. With skills in designing and managing Phase 1-4 studies as well as marketing strategies and competitive intelligence. Princeton Biotech specializes in: - New product planning and critical review - Clinical strategic development - Protocol development - Medical and scientific writing - Preparation of briefing package for FDA submissions (Pre-IND through NDA)